Clinical Trials Directory

Trials / Completed

CompletedNCT01321801

Pregabalin and Analgesia After Laparoscopic Cholecystectomy

Preoperative Use of Pregabalin and Analgesia Levels After Laparoscopic Cholecystectomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Larissa University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate how effective is the preoperative administration of pregabalin 600mg, to attenuate postoperative pain and opioids consumption after laparoscopic cholecystectomy.

Detailed description

Acute pain frequently occurs during the postoperative period.Not treated acute postoperative pain may predict the development of chronic pain.Recently, the analgesic effect of pregabalin, as a part of a multimodal analgesia, has been evaluated in many studies. They have shown that pregabalin may have a role in the post operative pain management, as an adjunct. Pregabalin is an anticonvulsant and anxiolytic drug, which have a more favorable pharmacokinetic profile from its predecessor gabapentin. Acute postoperative pain after laparoscopic cholecystectomy is complex in nature. Postoperative pain is the main complaint and the primary reason for delay discharge after laparoscopic cholecystectomy.The study includes patients undergoing laparoscopic cholecystectomy.

Conditions

Interventions

TypeNameDescription
DRUGPregabalinPreoperative administration of pregabalin 600mg
DRUGplaceboPreoperative administration of a matching placebo

Timeline

Start date
2009-11-01
Primary completion
2010-10-01
Completion
2010-12-01
First posted
2011-03-24
Last updated
2013-01-29

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT01321801. Inclusion in this directory is not an endorsement.

Pregabalin and Analgesia After Laparoscopic Cholecystectomy (NCT01321801) · Clinical Trials Directory